Xylem closed at $100.05 on Nov 5, down 0.99%, 33.9% below its 52-week closing high. Volume of 2.8M shares was 0.85× its 20-day average (close to normal).
Split-adjusted performance: -1.7% over one month, -13.5% over six months, -33.2% over one year.
In the quarter ended Sep 30, 2026, revenue was $2.20B, down 3.0% from a year earlier, with a net margin of 13.2%.
Short interest was 10.3M shares at the Oct 15 settlement (4.4% of float, 4.7 days to cover).